Skip to main content

Christina Applegate disclosed on her podcast that a recent medical review showed she does not have multiple sclerosis. The actress had gone public with an MS diagnosis more than five years earlier. She described the update as unexpected and emotionally difficult to process.

Podcast Announcement Brings New Questions

Applegate shared the details during an episode of MeSsy, the show she co-hosts with Jamie-Lynn Sigler. She explained that her doctor had paused an infusion treatment several years ago to monitor changes in her B-cell counts. The results did not align with expectations for someone living with MS, which prompted further investigation. The doctor delivered the revised assessment directly. Applegate recalled the moment with mixed feelings, noting that others around her reacted with relief while she felt unsettled. She has continued to experience significant symptoms that affect daily life, leaving her uncertain about the underlying cause.

Common Challenges in MS Diagnosis

Medical experts note that misdiagnoses of multiple sclerosis occur with some frequency. One neurologist cited on the podcast estimated that nearly one in five people initially told they have the condition later learn they do not. The disease lacks a single definitive test, and symptoms can overlap with other disorders. Applegate had undergone standard evaluations at the time of her original diagnosis, including a spinal tap and brain MRIs that revealed lesions. Those findings supported the earlier conclusion. She has since become an advocate for MS awareness while managing her own health challenges.

Impact on Symptoms and Advocacy

The revised information has not eased Applegate’s physical difficulties. She reported that her condition has, if anything, worsened over time. This leaves her and her medical team starting over to identify what has caused her symptoms since 2021. She expressed concern about how the news might affect others who followed her story. Applegate described feeling as though she had let supporters down, even though the change came from new clinical evidence rather than any error on her part.

Looking Ahead After the Update

Further testing is now underway to clarify her situation. Applegate emphasized that the process remains ongoing and that answers may take time. The development highlights how diagnostic conclusions can shift with additional data, even years later. Her experience underscores the importance of continued medical follow-up for anyone facing complex neurological symptoms.

AI Disclaimer: This article was created with the assistance of AI tools and reviewed by a human editor.